F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR

Key Points:

• The F.D.A. (Food and Drug Administration) has given approval to two new treatments for sickle cell disease, a genetic blood disorder that affects millions of people worldwide.
• One treatment involves gene therapy, where patients’ own stem cells are modified to produce healthy red blood cells. This is the first time a gene therapy has been approved for sickle cell disease.
• The other treatment uses CRISPR, a powerful gene-editing tool, to modify patients’ DNA and correct the mutation causing sickle cell disease.
• Both treatments have shown promising results in clinical trials, significantly reducing the frequency of pain crises and the need for blood transfusions in patients.
• However, the long-term effects and safety of these treatments still need to be closely monitored.

Hot take:

Treating sickle cell disease with gene therapy and CRISPR is a breakthrough that gives hope to millions, but let’s make sure we don’t create a new problem by accidentally turning someone into a superhero.

Original article:https://www.nytimes.com/2023/12/08/health/fda-sickle-cell-crispr.html